Jang, Subin
Ryder, Justin R.
Kelly, Aaron S.
Bomberg, Eric M.
Article History
Received: 19 September 2023
Revised: 29 July 2024
Accepted: 5 September 2024
First Online: 18 September 2024
Competing interests
: E.M.B. has been a site principal investigator and is a site co-investigator for Novo Nordisk. J.R. receives donation of drug/placebo for Boehringer Ingelheim. A.S.K. serves as an unpaid consultant for Novo Nordisk, Vivus, Eli Lilly, and Boehringer Ingelheim as well as receives donated drug/placebo from Novo Nordisk and Vivus for National Institute of Diabetes, and Digestive, and Kidney Diseases-funded clinical trials. All authors have no relevant conflicts of interest to disclose related to this work.
: Consent/assent were obtained from parents/guardians and participants, respectively.